148 related articles for article (PubMed ID: 30914530)
1. [A Case of Primary Small Cell Carcinoma in the Breast with Neoadjuvant Chemotherapy That Were Difficult to Select Chemotherapy].
Kimura Y; Kitagawa H; Funakoshi M; Mukaida H; Hirabayashi N; Kaneko M
Gan To Kagaku Ryoho; 2019 Feb; 46(2):263-266. PubMed ID: 30914530
[TBL] [Abstract][Full Text] [Related]
2. Multidisciplinary management of small cell carcinoma of the breast: a case report.
Murata T; Fujii M; Akahane K; Oda K; Ohama T; Yatabe Y; Kawada K
Nagoya J Med Sci; 2014 Feb; 76(1-2):173-80. PubMed ID: 25130003
[TBL] [Abstract][Full Text] [Related]
3. [A case of aggressive primary squamous cell carcinoma of the breast refractory to preoperative neoadjuvant chemotherapy].
Uchida N; Ishiguro K; Suda T; Nishimura M
Gan To Kagaku Ryoho; 2009 Dec; 36(13):2619-22. PubMed ID: 20009466
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Metaplastic Squamous Cell Carcinoma of the Breast Diagnosed after Neoadjuvant Chemotherapy].
Ishikawa N; Saimura M; Koga K; Anan K; Mitsuyama S; Tamiya S
Gan To Kagaku Ryoho; 2018 Jul; 45(7):1101-1103. PubMed ID: 30042281
[TBL] [Abstract][Full Text] [Related]
5. [A case of breast adenocarcinoma changed to squamous cell carcinoma after neoadjuvant chemotherapy].
Minagawa M; Kanzaki M; Takano Y; Nishikawa T; Deie K; Minami Y; Maeda M; Teshima S
Gan To Kagaku Ryoho; 2012 Jul; 39(7):1111-4. PubMed ID: 22790049
[TBL] [Abstract][Full Text] [Related]
6. [A case of premenopausal stage IV breast cancer responding to neoadjuvant endocrine therapy after chemotherapy with FEC].
Konishi K; Hasegawa N; Kaneko H; Iimura Y; Shoji Y; Kawabata M
Gan To Kagaku Ryoho; 2010 Jan; 37(1):111-3. PubMed ID: 20087042
[TBL] [Abstract][Full Text] [Related]
7. [A resected case of squamous cell carcinoma of the breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases].
Hiramatsu K; Kato K; Hirata A; Matsuba H; Hara T; Ito T; Miyata T; Akagawa T; Kutsuna Y; Machiki Y; Fujioka S
Gan To Kagaku Ryoho; 2007 Mar; 34(3):443-6. PubMed ID: 17353640
[TBL] [Abstract][Full Text] [Related]
8. Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy.
Yagata H; Kajiura Y; Yamauchi H
Breast Cancer; 2011 Jul; 18(3):165-73. PubMed ID: 21290263
[TBL] [Abstract][Full Text] [Related]
9. [Chemo-Resistant Breast Carcinoma with Cartilaginous Differentiation Manifestation after Neoadjuvant Chemotherapy-A Case Report].
Konishi K; Araya J; Nagabuchi M; Sakamoto T; Takakuwa Y; Sasaki M; Watanabe K; Hirano S
Gan To Kagaku Ryoho; 2021 Jul; 48(7):951-953. PubMed ID: 34267034
[TBL] [Abstract][Full Text] [Related]
10. A Case of Metaplastic Squamous Cell Carcinoma of the Breast that Showed a Pathological Complete Response After Neoadjuvant Chemotherapy with Weekly Paclitaxel.
Noro A; Ishitobi M; Hanamura N; Kashikura Y; Yamashita M; Kozuka Y; Saito K; Mizuno T; Ogawa T
Am J Case Rep; 2022 Jan; 23():e935035. PubMed ID: 35017459
[TBL] [Abstract][Full Text] [Related]
11. Successful neoadjuvant therapy with trastuzumab, paclitaxel and epirubicin for an elderly patient with inflammatory breast cancer.
Shimizu T; Hirano A; Watanabe O; Kinoshita J; Kimura K; Kamimura M; Domoto K; Kim N; Ogawa K; Fujibayashi M
Anticancer Res; 2010 Feb; 30(2):581-5. PubMed ID: 20332474
[TBL] [Abstract][Full Text] [Related]
12. [A case of giant breast cancer performed a radical excision after neoadjuvant chemotherapy].
Matsui H; Nagashima A; Kawaoka T; Hiraki S; Fukuda S
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2487-9. PubMed ID: 20037464
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of a dose-density regimen with fluorouracil, epirubicin, and cyclophosphamide on days 1 and 4 every 14 days with filgrastim support followed by weekly paclitaxel in women with primary breast cancer.
Pietri E; Andreis D; Fabbri F; Menna C; Schirone A; Kopf B; Rocca A; Amadori D; De Giorgi U
Oncologist; 2015 Mar; 20(3):239-40. PubMed ID: 25637379
[TBL] [Abstract][Full Text] [Related]
14. Primary Mammary Small Cell Carcinoma.
Shabbir SM; Raza SM; Bhatti SM
J Coll Physicians Surg Pak; 2018 Jun; 28(6):S112-S113. PubMed ID: 29866240
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer.
Heller W; Mazhar D; Ward R; Sinnett HD; Lowdell C; Phillips R; Shousha S; Fayaz A; Palmieri C; Coombes RC
Oncol Rep; 2007 Jan; 17(1):253-9. PubMed ID: 17143506
[TBL] [Abstract][Full Text] [Related]
16. Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm.
Calais G; Berger C; Descamps P; Chapet S; Reynaud-Bougnoux A; Body G; Bougnoux P; Lansac J; Le Floch O
Cancer; 1994 Aug; 74(4):1283-8. PubMed ID: 8055449
[TBL] [Abstract][Full Text] [Related]
17. Locally advanced breast cancer with bleeding - two cases effectively treated with bevacizumab plus weekly paclitaxel.
Ishizuna K; Ninomiya J; Ogawa T; Kojima M; Kawashima M; Nozaki M; Yamagishi H; Ueda Y
Gan To Kagaku Ryoho; 2014 May; 41(5):637-40. PubMed ID: 24917012
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of two different regimens as neoadjuvant chemotherapy for breast cancer].
Yang D; Tong F; Cao Y; Liu P; Zhou B; Liu H; Qiao X; Zhang J
Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):303-5. PubMed ID: 12515634
[TBL] [Abstract][Full Text] [Related]
20. Feasibility Study of Weekly Nanoparticle Albumin-Bound Paclitaxel (150 mg/m
Kojima Y; Kawamoto H; Nishikawa T; Hayami R; Shimo A; Haku E; Akiyama K; Tsugawa K
Clin Breast Cancer; 2018 Oct; 18(5):374-379. PubMed ID: 29452759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
